Viewing Study NCT04321603


Ignite Creation Date: 2025-12-24 @ 7:19 PM
Ignite Modification Date: 2025-12-28 @ 4:13 AM
Study NCT ID: NCT04321603
Status: WITHDRAWN
Last Update Posted: 2021-08-11
First Post: 2020-03-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
Sponsor: University of Maryland, Baltimore
Organization:

Study Overview

Official Title: Altering Mechanisms of Frailty in Persons Living With HIV Aged 50 to 65
Status: WITHDRAWN
Status Verified Date: 2021-08
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: COVID-19 prevented us from doing this human subjects study
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: ALTER
Brief Summary: People living with HIV are living longer as their disease is controlled with antiretroviral medications. Yet they are experiencing frailty more often and more than ten years earlier than those without HIV. In elderly persons without HIV, frailty is associated with decreased muscle strength and chronic inflammation. Less is known about what is driving early frailty in HIV or effective prevention measures for aging adults with HIV.

It may be that having HIV infection impairs energy production by mitochondria within the cells and contributes to the muscle weakness and inflammation accompanying frailty in people living with HIV . This study will examine the impact of six weeks of moderately paced walking on energy production in the cells, inflammation markers and frailty scores in people living with well-controlled HIV who are aged 50 to 65.
Detailed Description: None

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: